Skip to Main Content

Advertisement

Skip Nav Destination

With bb2121, Is CAR T-Cell Therapy Ready for Myeloma?

December 30, 2021

Noopur Raje, MD, discusses updated data from a phase I trial of the second-generation, anti-BCMA CAR T-cell therapy for relapsed/refractory myeloma.

Advertisement

Connect with us:

CURRENT ISSUE
August 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X